March 17, 2020
C-Path to lead multi-stakeholder engagement to enhance the pediatric medical device ecosystem
Related Posts
-
C-Path Receives Letter of Support from EMA on Duchenne Muscular Dystrophy Clinical Trial Simulation Platform -
C-Path and Mobilise-D Collaborate to Improve Impact on the Organizations’ Common Goals -
Webinar: TRxA 2023 Funding Opportunities -
Using Real World Data from CURE ID to Identify Drug Repurposing Opportunities in Mycology: Impact of Climate Change -
Polycystic Kidney Disease Drug Development: A Conference Report